Antengene Corporation Limited (HKG:6996)
Hong Kong · Delayed Price · Currency is HKD 2.840
-0.175 (-5.80%)
Oct 22, 2026, 4:08 PM HKT
Antengene Corporation Market Cap
Antengene Corporation has a market cap or net worth of 1.95 billion as of October 21, 2026. It is the 19,235th most valuable company in the world and the 852nd biggest in Hong Kong. Its market cap has decreased by 45.25% in one year.
Market Cap
1.95B
Enterprise Value
1.36B
Revenue
652.54M
Global Rank
Country Rank
#852 Hong Kong
PE Ratio
29.25
ChartMarket Cap Chart
Since November 20, 2020, Antengene Corporation's market cap has decreased from 12.21B to 1.95B, a decrease of -84.01%. That is a compound annual growth rate of -26.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 1.95B | -24.15% |
| Dec 31, 2025 | 2.57B | 482.90% |
| Dec 31, 2024 | 441.64M | -67.28% |
| Dec 29, 2023 | 1.35B | -61.17% |
| Dec 30, 2022 | 3.48B | -46.78% |
| Dec 31, 2021 | 6.53B | -43.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medtide | 2.80B |
| BioDlink International Company | 2.71B |
| Laekna | 2.67B |
| HJ Science | 2.56B |
| Jiangsu Recbio Technology | 2.41B |
| Mabpharm | 2.06B |
| AIM Vaccine | 1.96B |
| Clover Biopharmaceuticals | 1.94B |